Multiple sclerosis (MS) is a complex disease triggered by environmental and genetic agents, and clinically characterized by bout onset (BOMS) or progressive onset (PrMS). We collected clinical and familial aggregation data in a cohort of 518 Italian PrMS patients, and compared with 400 BOMS cases. An increased prevalence of MS in first-degree relatives of Italian PrMS was found. Familial aggregation is not influenced by probands' clinical course, and there is no disease course concordance within MS families. These data are useful in counseling MS patients affected with different clinical courses of the disease
Background: A subgroup of patients diagnosed with multiple sclerosis (MS) present with no oligoclona...
The contribution of genetic variants underlying the susceptibility to different clinical courses of ...
Background: The role played by genetic factors in influencing the clinical course of multiple sclero...
Multiple sclerosis (MS) is a complex disease triggered by environmental and genetic agents, and clin...
Supplemental data at Neurology.org/nn Impact of MS genetic loci on familial aggregation, clinical ph...
The pathophysiology of primary progressive (PP) multiple sclerosis (MS) involves diffuse axonal dege...
Multiple sclerosis (MS) is known to accumulate within families. The magnitude of the familial risk, ...
As part of a linkage study, we obtained clinical, demographic, and genetic information on 210 famili...
Familial aggregation is a cardinal epidemiological feature of multiple sclerosis, but few investigat...
Objectives - An exploratory study has been carried out to assess the association of autoimmune disea...
Data on familial recurrence rates of complex diseases such as multiple sclerosis give important hint...
GENETIC-environmental interactions probably underlie spontaneous human autoimmune disorders, a categ...
Objective To investigate whether the timing of secondary or primary progression is different between...
Background: Multiple Sclerosis (MS) is a chronic inflammatory and neurodegenerative demyelinating di...
Environmental and genetic factors seem to play a pathogenetic role in multiple sclerosis (MS). The g...
Background: A subgroup of patients diagnosed with multiple sclerosis (MS) present with no oligoclona...
The contribution of genetic variants underlying the susceptibility to different clinical courses of ...
Background: The role played by genetic factors in influencing the clinical course of multiple sclero...
Multiple sclerosis (MS) is a complex disease triggered by environmental and genetic agents, and clin...
Supplemental data at Neurology.org/nn Impact of MS genetic loci on familial aggregation, clinical ph...
The pathophysiology of primary progressive (PP) multiple sclerosis (MS) involves diffuse axonal dege...
Multiple sclerosis (MS) is known to accumulate within families. The magnitude of the familial risk, ...
As part of a linkage study, we obtained clinical, demographic, and genetic information on 210 famili...
Familial aggregation is a cardinal epidemiological feature of multiple sclerosis, but few investigat...
Objectives - An exploratory study has been carried out to assess the association of autoimmune disea...
Data on familial recurrence rates of complex diseases such as multiple sclerosis give important hint...
GENETIC-environmental interactions probably underlie spontaneous human autoimmune disorders, a categ...
Objective To investigate whether the timing of secondary or primary progression is different between...
Background: Multiple Sclerosis (MS) is a chronic inflammatory and neurodegenerative demyelinating di...
Environmental and genetic factors seem to play a pathogenetic role in multiple sclerosis (MS). The g...
Background: A subgroup of patients diagnosed with multiple sclerosis (MS) present with no oligoclona...
The contribution of genetic variants underlying the susceptibility to different clinical courses of ...
Background: The role played by genetic factors in influencing the clinical course of multiple sclero...